Suppr超能文献

与三甲胺尿症相关的人类FMO3基因变异的功能特征

Functional characterization of genetic variants of human FMO3 associated with trimethylaminuria.

作者信息

Yeung Catherine K, Adman Elinor T, Rettie Allan E

机构信息

University of Washington School of Pharmacy, Department of Medicinal Chemistry, Box 357610, Seattle, WA 98195, USA.

出版信息

Arch Biochem Biophys. 2007 Aug 15;464(2):251-9. doi: 10.1016/j.abb.2007.04.014. Epub 2007 May 2.

Abstract

Impaired conversion of trimethylamine to trimethylamine N-oxide by human flavin containing monooxygenase 3 (FMO3) is strongly associated with primary trimethylaminuria, also known as 'fish-odor' syndrome. Numerous non-synonymous mutations in FMO3 have been identified in patients suffering from this metabolic disorder (e.g., N61S, M66I, P153L, and R492W), but the molecular mechanism(s) underlying the functional deficit attributed to these alleles has not been elucidated. The purpose of the present study was to determine the impact of these disease-associated genetic variants on FMO3 holoenzyme formation and on steady-state kinetic parameters for metabolism of several substrates, including trimethylamine. For comparative purposes, several common allelic variants not associated with primary trimethylaminuria (i.e., E158K, V257M, E308G, and the E158K/E308G haplotype) were also analyzed. When recombinantly expressed in insect cells, only the M66I and R492W mutants failed to incorporate/retain the FAD cofactor. Of the remaining mutant proteins P153L and N61S displayed substantially reduced (<10%) catalytic efficiencies for trimethylamine N-oxygenation relative to the wild-type enzyme. For N61S, reduced catalytic efficiency was solely a consequence of an increased K(m), whereas for P153L, both K(m) and k(cat) were altered. Similar results were obtained when benzydamine N-oxygenation was monitored. A homology model for FMO3 was constructed based on the crystal structure for yeast FMO which places the N61 residue alone, of the mutants analyzed here, in close proximity to the FAD catalytic center. These data demonstrate that primary trimethylaminuria is multifactorial in origin in that enzyme dysfunction can result from kinetic incompetencies as well as impaired assembly of holoprotein.

摘要

人类含黄素单加氧酶3(FMO3)将三甲胺转化为三甲胺N-氧化物的功能受损与原发性三甲胺尿症(也称为“鱼腥味”综合征)密切相关。在患有这种代谢紊乱的患者中已鉴定出FMO3中的许多非同义突变(例如,N61S、M66I、P153L和R492W),但这些等位基因导致功能缺陷的分子机制尚未阐明。本研究的目的是确定这些与疾病相关的基因变异对FMO3全酶形成以及几种底物(包括三甲胺)代谢的稳态动力学参数的影响。为了进行比较,还分析了几种与原发性三甲胺尿症无关的常见等位基因变异(即E158K、V257M、E308G和E158K/E308G单倍型)。当在昆虫细胞中重组表达时,只有M66I和R492W突变体未能结合/保留FAD辅因子。在其余的突变蛋白中,相对于野生型酶,P153L和N61S对三甲胺N-氧化的催化效率大幅降低(<10%)。对于N61S,催化效率降低仅是K(m)增加的结果,而对于P153L,K(m)和k(cat)均发生了改变。监测苄达明N-氧化时也获得了类似的结果。基于酵母FMO的晶体结构构建了FMO3的同源模型,该模型将此处分析的突变体中仅N61残基置于靠近FAD催化中心的位置。这些数据表明,原发性三甲胺尿症的起源是多因素的,因为酶功能障碍可能是由于动力学能力不足以及全蛋白组装受损所致。

相似文献

1
Functional characterization of genetic variants of human FMO3 associated with trimethylaminuria.
Arch Biochem Biophys. 2007 Aug 15;464(2):251-9. doi: 10.1016/j.abb.2007.04.014. Epub 2007 May 2.
5
FMO3 allelic variants in Sicilian and Sardinian populations: trimethylaminuria and absence of fish-like body odor.
Gene. 2013 Feb 25;515(2):410-5. doi: 10.1016/j.gene.2012.12.047. Epub 2012 Dec 21.
6
Inactivation mechanism of N61S mutant of human FMO3 towards trimethylamine.
Sci Rep. 2017 Nov 7;7(1):14668. doi: 10.1038/s41598-017-15224-9.
7
Novel variants of the human flavin-containing monooxygenase 3 (FMO3) gene associated with trimethylaminuria.
Mol Genet Metab. 2009 Jun;97(2):128-35. doi: 10.1016/j.ymgme.2009.02.006. Epub 2009 Feb 27.
8
Deleterious mutations in the flavin-containing monooxygenase 3 (FMO3) gene causing trimethylaminuria.
Pharmacogenetics. 2003 Aug;13(8):495-500. doi: 10.1097/00008571-200308000-00007.

引用本文的文献

2
Trimethylamine-N-Oxide (TMAO) as a Rising-Star Metabolite: Implications for Human Health.
Metabolites. 2025 Mar 24;15(4):220. doi: 10.3390/metabo15040220.
6
Association of FMO3 rs1736557 polymorphism with clopidogrel response in Chinese patients with coronary artery disease.
Eur J Clin Pharmacol. 2021 Mar;77(3):359-368. doi: 10.1007/s00228-020-03024-6. Epub 2020 Oct 21.
8
Association of Variants with Blood Pressure in the Atherosclerosis Risk in Communities Study.
Int J Hypertens. 2019 Feb 18;2019:2137629. doi: 10.1155/2019/2137629. eCollection 2019.
9
Inactivation mechanism of N61S mutant of human FMO3 towards trimethylamine.
Sci Rep. 2017 Nov 7;7(1):14668. doi: 10.1038/s41598-017-15224-9.
10
Genetic and Nongenetic Factors Associated with Protein Abundance of Flavin-Containing Monooxygenase 3 in Human Liver.
J Pharmacol Exp Ther. 2017 Nov;363(2):265-274. doi: 10.1124/jpet.117.243113. Epub 2017 Aug 17.

本文引用的文献

1
Mechanism of action of a flavin-containing monooxygenase.
Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):9832-7. doi: 10.1073/pnas.0602398103. Epub 2006 Jun 15.
2
Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism.
Pharmacol Ther. 2005 Jun;106(3):357-87. doi: 10.1016/j.pharmthera.2005.01.001.
4
Benzydamine metabolism in vivo is impaired in patients with deficiency of flavin-containing monooxygenase 3.
Pharmacogenetics. 2004 Nov;14(11):775-7. doi: 10.1097/00008571-200411000-00009.
5
Protein measurement with the Folin phenol reagent.
J Biol Chem. 1951 Nov;193(1):265-75.
6
Trimethylaminuria and a human FMO3 mutation database.
Hum Mutat. 2003 Sep;22(3):209-13. doi: 10.1002/humu.10252.
7
ExPASy: The proteomics server for in-depth protein knowledge and analysis.
Nucleic Acids Res. 2003 Jul 1;31(13):3784-8. doi: 10.1093/nar/gkg563.
9
Human flavin-containing monooxygenase: substrate specificity and role in drug metabolism.
Curr Drug Metab. 2000 Sep;1(2):181-91. doi: 10.2174/1389200003339135.
10
In vivo variability of TMA oxidation is partially mediated by polymorphisms of the FMO3 gene.
Mol Genet Metab. 2001 Jul;73(3):224-9. doi: 10.1006/mgme.2001.3189.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验